These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 29457868

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, Saayman E, Moorhouse M, Venter WDF, Rees H, TAPS Demonstration Project Team.
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [Abstract] [Full Text] [Related]

  • 4. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V, Shunmugam M, Rawat S, Baruah D, Nelson R, Newman PA.
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [Abstract] [Full Text] [Related]

  • 5. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H.
    PLoS One; 2019 Feb; 14(4):e0212271. PubMed ID: 30964874
    [Abstract] [Full Text] [Related]

  • 6. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce IV, Reddy K, Friedland BA, Palanee-Phillips T, Mathur S.
    BMC Womens Health; 2024 Aug 22; 24(1):462. PubMed ID: 39174929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.
    Stoebenau K, Muchanga G, Ahmad SS, Bwalya C, Mwale M, Toussaint S, Maambo C, Peters CJ, Baumhart C, Mwango LK, Lavoie MC, Claassen CW.
    BMC Public Health; 2024 Jun 17; 24(1):1617. PubMed ID: 38886691
    [Abstract] [Full Text] [Related]

  • 9. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA, Dada S, Martin CE, Mullick S.
    J Int AIDS Soc; 2024 May 17; 27(5):e26249. PubMed ID: 38695102
    [Abstract] [Full Text] [Related]

  • 10. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, Smit JA, Kimani J.
    J Int AIDS Soc; 2014 May 17; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [Abstract] [Full Text] [Related]

  • 11. Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study.
    Mpunga E, Persaud N, Akolo C, Boyee D, Kamanga G, Trapence G, Chilongozi D, Ruberintwari M, Masankha Banda L.
    JMIR Public Health Surveill; 2021 Oct 27; 7(10):e26177. PubMed ID: 34228627
    [Abstract] [Full Text] [Related]

  • 12. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V, Nouaman M, Plazy M, Masumbuko JM, Anoma C, Kouame S, Danel C, Eholie SP, Larmarange J, ANRS 12361 PrEP-CI Study group.
    BMJ Open; 2020 Jan 08; 10(1):e028508. PubMed ID: 31919122
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
    Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, Pidwell T, Mendel E, Fynn L, Jones K, Wiesner L, Slack C, Strode A, Spiegel H, Hosek S, Rooney J, Gray G, Bekker LG.
    Lancet Child Adolesc Health; 2020 Dec 08; 4(12):875-883. PubMed ID: 33222803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ, Ahmed N, Tshabalala G, Wu M, Mulaudzi M, Hornschuh S, Atujuna M, Muhumuza R, Ssemata AS, Stranix-Chibanda L, Nematadzira T, Bekker LG, Martinson N, Seeley J, Fox J.
    PLoS One; 2023 Dec 08; 18(6):e0287627. PubMed ID: 37384792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
    Giovenco D, Kuo C, Underhill K, Hoare J, Operario D.
    Arch Sex Behav; 2021 Oct 08; 50(7):2921-2931. PubMed ID: 34561792
    [Abstract] [Full Text] [Related]

  • 20. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, Bekker LG.
    PLoS One; 2018 Oct 08; 13(2):e0191251. PubMed ID: 29420549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.